COMMUNIQUÉS West-GlobeNewswire

T2 Biosystems Reports Granting of Inducement Awards

05/10/2018 - 13:00

LEXINGTON, Mass., Oct. 05, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]

Canada House Wellness Group Inc Announces Scott Purdy’s Departure

05/10/2018 - 13:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc ("Canada House" or the "Company") (CSE: CHV) announces that [...]

K2M Group Holdings, Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders

05/10/2018 - 12:30

LEESBURG, Va., Oct. 05, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq: KTWO) (the “Company” or “K2M”), announced today that it has set a record date and meeting date for a special meeting of its stockholders [...]

RadNet Enters the Long Island, New York Market with the Acquisition of Medical Arts Radiology

05/10/2018 - 12:00

LOS ANGELES, Oct. 05, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it acquired [...]

RavenQuest Engages Link Media LLC to Provide Market Awareness to the USA Market

05/10/2018 - 12:00

VANCOUVER, British Columbia, Oct. 05, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) RavenQuest BioMed Inc. has retained Link Media LLC to [...]

Healthy Stomach Day – aroused wide interest and increased awareness on stomach health

05/10/2018 - 11:10

Press release 5th of October 2018 at 12.10 PM local time International Healthy Stomach Initiative (HSI) organized on Tuesday, October 2, 2018 in several countries all over the world public events aiming to increase the [...]

Terveystalo Plc: The Finnish Competition and Consumer Authority applies for an extension for investigating the transaction between Terveystalo and Attendo

05/10/2018 - 08:00

Terveystalo Plc Stock Exchange release 5 October 2018 at 09:00 a.m EEST Terveystalo Plc ("Terveystalo") has on 17 May 2018 signed an agreement to acquire the Finnish healthcare operations of Attendo AB (publ) ("Attendo [...]

Rule 2.9 Announcement

05/10/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 5 October 2018 [...]

VALNEVA Announces FDA Approval of Accelerated IXIARO® Vaccination Schedule

05/10/2018 - 07:01

Valneva Announces FDA Approval of Accelerated IXIARO ® Vaccination Schedule Saint Herblain (France), October 5, 2018 - Valneva SE ("Valneva" or "the Company"), a commercial stage biotech company focused on developing [...]

VALNEVA : la FDA approuve un schéma accéléré de vaccination pour IXIARO®

05/10/2018 - 07:01

Valneva: la FDA approuve un schéma accéléré de vaccination pour IXIARO ® Saint Herblain (France), 5 octobre 2018 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie dédiée au développement, à la [...]

Probiodrug Reports Management Changes

05/10/2018 - 07:00

Probiodrug Reports Management Changes HALLE (SAALE), Germany, October 5th, 2018 - Probiodrug AG ("Probiodrug", Euronext: PBD), a clinical stage biopharmaceutical company developing novel therapeutic solutions to treat [...]

ObsEva SA Announces Phase 3 IMPLANT 2 Clinical Trial Results of Nolasiban in IVF to be Presented at Annual ASRM Meeting Tuesday October 9, 2018

05/10/2018 - 07:00

Recipient of Prize Paper Award from the Society for Assisted Reproductive Technology (SART) Geneva, Switzerland and Boston, MA - October 5, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage [...]

Canada House Wellness Group Inc. Announces Closing of First Tranche under Alumina Facility

05/10/2018 - 04:34

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc ("Canada House" or the "Company") (CSE: CHV) is pleased to [...]

MediciNova Announces FDA Grants Orphan Drug Designation to MN-166 (ibudilast) for Glioblastoma

05/10/2018 - 01:00

LA JOLLA, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]

Emergent BioSolutions Completes Acquisition of Specialty Vaccines Company PaxVax

05/10/2018 - 00:27

GAITHERSBURG, Md., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its acquisition of PaxVax, a company focused on developing, manufacturing, and [...]

LeMaitre Vascular Announces Preliminary Q3 2018 Results

04/10/2018 - 22:48

BURLINGTON, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, announced today Q3 2018 preliminary unaudited results, provided Q4 2018 [...]

Insmed Extends Patent Protection in Japan to 2033

04/10/2018 - 22:30

New Patent Adds 7 ½ Years of Market Exclusivity in Japan BRIDGEWATER, N.J., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients [...]

Study Demonstrating Globus Medical’s Expandable Technology Improves Lordosis and Reduces Subsidence Awarded Best Paper at SMISS

04/10/2018 - 22:30

AUDUBON, Pa., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, announced today that a recent clinical study evaluating static versus expandable lateral [...]

Corvus Pharmaceuticals to Present Data on Lead Programs at the European Society for Medical Oncology (ESMO) 2018 Congress and the Society for Immunotherapy of Cancer (SITC) Annual Meeting

04/10/2018 - 22:15

BURLINGAME, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]